Evidence map›Paper›PMID 41682833›Full record

ArticleJournal of clinical medicine2026

Vascular Access 4.0 for Hemodialysis: Toward a Needle-Free, Smart, Closed, and Connected System.

Bernard Canaud, Hafedh Fessi, Michael Rys, Eric Jean, Ludovic Canaud

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bernard CanaudSchool of Medicine, Montpellier University, 34090 Montpellier, France.ORCID 0000-0001-6854-2816
Hafedh FessiNephrology & Dialysis Department, Hôpital Le Mans-University Paris Sorbonne, 75006 Paris, France.ORCID 0000-0002-7458-2862
Michael RysSÆPTUM SAS, 14200 Hérouville-Saint-Clair, France.
Eric JeanSÆPTUM SAS, 14200 Hérouville-Saint-Clair, France.
Ludovic CanaudVascular and Thoracic Surgery Department, University Hospital Arnaud de Villeneuve, CHU Montpellier, 34295 Montpellier, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular access remains the cornerstone of effective hemodialysis but also constitutes a major source of burden, including dysfunctions, infections, patient discomfort, and other access-related morbidities. As dialysis care evolves, there is a pressing need to move beyond conventional approaches, marked by repeated needle punctures and open connection systems, toward safer, more comfortable, and technologically advanced solutions. This narrative article presents a forward-looking vision of vascular access connectivity supported in current clinical and technological knowledge. It explores how emerging connectivity, particularly needle-free port systems, could reshape the future of dialysis care. We briefly review existing vascular access modalities, including central venous catheters (CVCs) and arteriovenous (AV) accesses, along with their associated limitations. Special focus is given to the burden of infection, patient-reported discomfort, and workflow inefficiencies. We then examine emerging closed-system technologies designed to reduce contamination risk, improve patient experience, and potentially support long-term clinical outcomes. Drawing on advances in material science, biomedical engineering, and infection prevention, we outline a forward-looking vision for vascular access that aligns with patient-centered care, facilitates home-based treatment and remote connectivity, and anticipates future developments, such as wearable artificial kidneys within a value-based healthcare framework. However, the clinical adoption of these new technologies will require careful evaluation of long-term safety, durability, cost-effectiveness, training requirements, and real-world performance, underscoring the need to balance innovation-driven benefits against practical, regulatory, and organizational challenges.

Indexed as

end-stage kidney diseasehemodialysiskidney replacement therapyvascular access

Identifiers

PMID41682833
PMCPMC12898385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.